Tulsi Gabbard on health: what the evidence says · JRE #1170

FACT CHECK // JRE #1170 // EXHIBIT LOG
THE JOE ROGAN EXPERIENCE
CLAIM CMRM2Q2KSTATUS: PUBLISHED
SUBJECT: HEALTH
Timestamp1:35:23
RulingNeeds Context

Not a true/false call. Every claim is logged with its sources; read the exhibits below.

// THE CLAIM · ON TAPE
there's a John Hopkins study. There's several studies that they're doing right now that they're trying to show that there's a direct correlation between use of psilocybin in these clinical situations where they're curing cigarettes, heroin, all these different addictions
Tulsi Gabbard@ 1:35:23
Watch on YouTubeJUMP TO 1:35:23

What the evidence says 01 / RECORD

Johns Hopkins has run psilocybin trials for addiction, and a randomized pilot (82 smokers) found that 40.5% of those given a single high dose of psilocybin plus cognitive behavioral therapy achieved biochemically verified abstinence at six months, versus 10% given a nicotine patch plus the same therapy; the trial was unblinded and the authors describe psilocybin as a 'promising candidate' moving toward the FDA approval process, not a cure. For heroin and other opioids, human clinical evidence is far earlier-stage: supporting data is still limited largely to animal studies, and trials testing psilocybin for opioid relapse prevention were only beginning as of the mid-2020s. NIDA characterizes psilocybin research across substance use disorders as preliminary, noting it 'may be helpful' but requires further large-scale trials, not an established or approved 'cure.' Overall, the claim overstates both the strength and the certainty of the evidence, particularly for heroin, and 'curing' misrepresents research still in pilot and early trial phases.

/// factcheckjoerogan.com